Advances in pathogenesis and current therapeutic strategies for cardiorenal syndrome

Life Sciences

Volumn 99, Issue 1-2, 2014, Pages 1-6

  Du, Yujun ^a   Li, Xiujiang ^b   Liu, Bin ^a  

^a JILIN UNIVERSITY   (China)

^b Jilin Tumor Hospital   (China)

Author keywords

Cardiorenal syndrome; Chronic heart failure; Pathogenesis; Therapy

Indexed keywords

ADENOSINE RECEPTOR BLOCKING AGENT; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE; FERROPORTIN; INTERLEUKIN 1; INTERLEUKIN 6; IRON; LOOP DIURETIC AGENT; NATRIURETIC FACTOR; NEUROHORMONE; PENTRAXIN 3; REACTIVE OXYGEN METABOLITE; RECEPTOR BLOCKING AGENT; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D;

ADRENERGIC SYSTEM; AEROBIC METABOLISM; ANEMIA; ATHEROSCLEROSIS; CARDIORENAL SYNDROME; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEART VENTRICLE REMODELING; HEMODYNAMICS; HUMAN; HYPERTENSION; IRON ABSORPTION; IRON DEFICIENCY; KIDNEY PERFUSION; OXIDATIVE STRESS; PATHOGENESIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SODIUM RETENTION; ULTRAFILTRATION; VITAMIN SUPPLEMENTATION;

CARDIORENAL SYNDROME; CHRONIC HEART FAILURE; PATHOGENESIS; THERAPY;

CARDIO-RENAL SYNDROME; FUROSEMIDE; HUMANS; PURINERGIC P1 RECEPTOR ANTAGONISTS;

EID: 84896728827     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2013.10.003     Document Type: Review

References (68)

1. S.D. Anker, and A.J. Coats How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH Int J Cardiol 86 2-3 2002 123 130
2. S.D. Anker, J. Comin Colet, G. Filippatos, R. Willenheimer, K. Dickstein, and H. Drexler et al. Ferric carboxymaltose in patients with heart failure and iron deficiency N Engl J Med 361 25 2009 2436 2448
3. G.L. Bakris, and M.R. Weir Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? Arch Intern Med 160 5 2000 685 693
4. B.A. Bart, A. Boyle, A.J. Bank, I. Anand, M.T. Olivari, and M. Kraemer et al. Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients with Decompensated Congestive Heart Failure (RAPID-CHF) trial J Am Coll Cardiol 46 11 2005 2043 2046
5. B.A. Bart, S.R. Goldsmith, K.L. Lee, M.M. Givertz, C.M. O'Connor, and D.A. Bull et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome N Engl J Med 367 24 2012 2296 2304
6. J.E. Blair, A. Manuchehry, A. Chana, J. Rossi, R.W. Schrier, and J.C. Burnett et al. Prognostic markers in heart failure - congestion, neurohormones, and the cardiorenal syndrome Acute Card Care 9 2007 207 213
7. J.S. Bock, and S.S. Gottlieb Cardiorenal syndrome: new perspectives Circulation 121 23 2010 2592 2600
8. L.G. Bongartz, M.J. Cramer, P.A. Doevendans, J.A. Joles, and B. Braam The severe cardiorenal syndrome: 'Guyton revisited' Eur Heart J 26 2005 11 17
9. A. Brammah, S. Robertson, G. Tait, and C. Isles Bilateral renovascular disease causing cardiorenal failure BMJ 326 2003 489 491
10. G. Cice, A. Di Benedetto, S. D'Isa, A. D'Andrea, D. Marcelli, and E. Gatti et al. Effects of telmisartan added to angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart failure a double-blind, placebo-controlled trial J Am Coll Cardiol 56 21 2010 1701 1708
11. R.J. Cody, S. Ljungman, A.B. Covit, S.H. Kubo, J.E. Sealey, and K. Pondolfino et al. Regulation of glomerular filtration rate in chronic congestive heart failure patients Kidney Int 34 3 1988 361 367
12. P.C. Colombo, A. Ganda, J. Lin, D. Onat, A. Harxhi, and J.E. Iyasere et al. Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome Heart Fail Rev 17 2 2012 177 190
13. M.R. Costanzo, M.E. Guglin, M.T. Saltzberg, M.L. Jessup, B.A. Bart, and J.R. Teerlink et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure J Am Coll Cardiol 49 6 2007 675 683
14. R.R. Crichton, S. Wilmet, R. Legssyer, and R.J. Ward Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells J Inorg Biochem 91 1 2002 9 18
15. K. Damman, G. Navis, T.D. Smilde, A.A. Voors, W. van der Bij, and D.J. van Veldhuisen et al. Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction Eur J Heart Fail 9 9 2007 872 878
16. K. Damman, V.M. van Deursen, G. Navis, A.A. Voors, D.J. van Veldhuisen, and H.L. Hillege Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease J Am Coll Cardiol 53 7 2009 582 588
17. D. De Backer, P. Biston, J. Devriendt, C. Madl, D. Chochrad, and C. Aldecoa et al. Comparison of dopamine and norepinephrine in the treatment of shock N Engl J Med 362 9 2010 779 789
18. G.M. Felker, K.L. Lee, D.A. Bull, M.M. Redfield, L.W. Stevenson, and S.R. Goldsmith et al. Diuretic strategies in patients with acute decompensated heart failure N Engl J Med 364 9 2011 797 805
19. D.E. Forman, J. Butler, Y. Wang, W.T. Abraham, C.M. O'Connor, and S.S. Gottlieb et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure J Am Coll Cardiol 43 1 2004 61 67
20. A. Gill, K. Wortham, D. Costa, W. Davis, B. Ticho, and E. Whalley Protective effect of tonapofylline (BG9928), an adenosine A1 receptor antagonist, against cisplatin-induced acute kidney injury in rats Am J Nephrol 30 6 2009 521 526
21. S.S. Gottlieb, S.L. Skettino, A. Wolff, E. Beckman, M.L. Fisher, and R. Freudenberger et al. Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure J Am Coll Cardiol 35 1 2000 56 59
22. S.S. Gottlieb, D.C. Brater, I. Thomas, E. Havranek, R. Bourge, and S. Goldman et al. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy Circulation 105 11 2002 1348 1353
23. S.S. Gottlieb, M.M. Givertz, M. Metra, K. Gergich, S. Bird, and C. Jones-Burton et al. The effects of adenosine A(1) receptor antagonism in patients with acute decompensated heart failure and worsening renal function: the REACH UP study J Card Fail 16 9 2010 714 719
24. B. Greenberg, I. Thomas, D. Banish, S. Goldman, E. Havranek, and B.M. Massie et al. Effects of multiple oral doses of an A1 adenosine antagonist, BG9928, in patients with heart failure: results of a placebo-controlled, dose-escalation study J Am Coll Cardiol 50 7 2007 600 606
25. L. Gullestad, and P. Aukrust Review of trials in chronic heart failure showing broad-spectrum anti-inflammatory approaches Am J Cardiol 95 11A 2005 17C 23C [discussion 38C-40C]
26. L. Hallberg Perspectives on nutritional iron deficiency Annu Rev Nutr 21 2001 1 21
27. S. Heymans, E. Hirsch, S.D. Anker, P. Aukrust, J.L. Balligand, and J.W. Cohen-Tervaert et al. Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology Eur J Heart Fail 11 2 2009 119 129
28. J.C. Jentzer, T.A. DeWald, and A.F. Hernandez Combination of loop diuretics with thiazide-type diuretics in heart failure J Am Coll Cardiol 56 19 2010 1527 1534
29. B. Kestenbaum, R. Katz, I. de Boer, A. Hoofnagle, M.J. Sarnak, and M.G. Shlipak et al. Vitamin D, parathyroid hormone, and cardiovascular events among older adults J Am Coll Cardiol 58 14 2011 1433 1441
30. D.H. Kim, S. Sabour, U.N. Sagar, S. Adams, and D.J. Whellan Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004) Am J Cardiol 102 11 2008 1540 1544
31. E.J. Kraut, S. Chen, N.E. Hubbard, K.L. Erickson, and D.H. Wisner Tumor necrosis factor depresses myocardial contractility in endotoxemic swine J Trauma 46 5 1999 900 906
32. C.J. Lavie, J.H. Lee, and R.V. Milani Vitamin D and cardiovascular disease will it live up to its hype? J Am Coll Cardiol 58 15 2011 1547 1556
33. P. Ledoux Cardiorenal syndrome (in French) L'Avenir Méd 48 1951 149 153
34. Z. Li, C. Tenhoor, T. Marbury, S. Swan, Y. Zhu, and B. Ticho Pharmacokinetics and pharmacodynamics of tonapofylline in subjects with severe renal impairment and in elderly subjects Int J Clin Pharmacol Ther 49 9 2011 563 570
35. D.L. Mann, J.J. McMurray, M. Packer, K. Swedberg, J.S. Borer, and W.S. Colucci et al. Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL) Circulation 109 13 2004 1594 1602
36. P.A. McCullough, and A. Ahmad Cardiorenal syndromes World J Cardiol 3 1 2011 26 1 9
37. J.J. McMurray, S. Adamopoulos, S.D. Anker, A. Auricchio, M. Böhm, and K. Dickstein et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur Heart J 33 14 2012 1787 1847
38. M. Metra, B. Davison, L. Bettari, H. Sun, C. Edwards, and V. Lazzarini et al. Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function Circ Heart Fail 5 1 2012 54 62
39. W. Mullens, Z. Abrahams, H.N. Skouri, G.S. Francis, D.O. Taylor, and R.C. Starling et al. Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function? J Am Coll Cardiol 51 3 2008 300 306
40. J. Niebauer, H.D. Volk, M. Kemp, M. Dominguez, R.R. Schumann, and M. Rauchhaus et al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study Lancet 353 9167 1999 1838 1842
41. A. Nohria, V. Hasselblad, A. Stebbins, D.F. Pauly, G.C. Fonarow, and M. Shah et al. Cardiorenal interactions: insights from the ESCAPE trial J Am Coll Cardiol 51 13 2008 1268 1274
42. M. Ogawa, J. Suzuki, K. Takayama, T. Senbonmatsu, Y. Hirata, and R. Nagai et al. Impaired post-infarction cardiac remodeling in chronic kidney disease is due to excessive renin release Lab Investig 92 12 2012 1766 1776
43. D.O. Okonko, A.K. Mandal, C.G. Missouris, and P.A. Poole-Wilson Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival J Am Coll Cardiol 58 12 2011 1241 1251
44. A. Parikh, S. Natarajan, S.R. Lipsitz, and S.D. Katz Iron deficiency in community-dwelling US adults with self-reported heart failure in the National Health and Nutrition Examination Survey III: prevalence and associations with anemia and inflammation Circ Heart Fail 4 5 2011 599 606
45. K. Rafiq, T. Noma, Y. Fujisawa, Y. Ishihara, Y. Arai, and A.H. Nabi et al. Renal sympathetic denervation suppresses de novo podocyte injury and albuminuria in rats with aortic regurgitation Circulation 125 11 2012 1402 1413
46. M. Rauchhaus, W. Doehner, D.P. Francis, C. Davos, M. Kemp, and C. Liebenthal et al. Plasma cytokine parameters and mortality in patients with chronic heart failure Circulation 102 25 2000 3060 3067
47. C. Ronco, and M. Cozzolino Mineral metabolism abnormalities and vitamin D receptor activation in cardiorenal syndromes Heart Fail Rev 17 2 2012 211 220
48. C. Ronco, M. Haapio, A.A. House, N. Anavekar, and R. Bellomo Cardiorenal syndrome J Am Coll Cardiol 52 2008 1527 1539
49. C. Ronco, P. McCullough, S.D. Anker, I. Anand, N. Aspromonte, and S.M. Bagshaw et al. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative Eur Heart J 31 6 2010 703 711
50. C. Ronco, D. Cruz, and B.W. Noland Neutrophil gelatinase-associated lipocalin curve and neutrophil gelatinase-associated lipocalin extended-range assay: a new biomarker approach in the early diagnosis of acute kidney injury and cardio-renal syndrome Semin Nephrol 32 1 2012 121 128
51. L. Rothermund, M. Lorenz, A. Schnieber, J. Eberson, I. Bauhaus, and M. Bernhard Haug et al. Impact of nephron number dosing on cardiorenal damage and effects of ACE inhibition Am J Hypertens 24 4 2011 474 481
52. M. Sarraf, and R.W. Schrier Cardiorenal syndrome in acute heart failure syndromes Int J Nephrol 2011 2011 293938
53. M. Sarraf, A. Masoumi, and R.W. Schrier Cardiorenal syndrome in acute decompensated heart failure Clin J Am Soc Nephrol 4 2009 2013 2026
54. J. Schnermann, and J.P. Briggs Tubuloglomerular feedback: mechanistic insights from gene-manipulated mice Kidney Int 74 4 2008 418 426
55. R.W. Schrier, and W.T. Abraham Hormones and hemodynamics in heart failure N Engl J Med 341 8 1999 577 585
56. K. Schümann, T. Ettle, B. Szegner, B. Elsenhans, and N.W. Solomons On risks and benefits of iron supplementation recommendations for iron intake revisited J Trace Elem Med Biol 21 3 2007 147 168
57. D.S. Silverberg The role of erythropoiesis stimulating agents and intravenous (IV) iron in the cardio renal anemia syndrome Heart Fail Rev 16 6 2011 609 614
58. L.W. Stevenson, J.H. Tillisch, M. Hamilton, M. Luu, C. Chelimsky-Fallick, and J. Moriguchi et al. Importance of hemodynamic response to therapy in predicting survival with ejection fraction less than or equal to 20% secondary to ischemic or nonischemic dilated cardiomyopathy Am J Cardiol 66 19 1990 1348 1354
59. H. Suzuki, Y. Kanno, S. Sugahara, N. Ikeda, J. Shoda, and T. Takenaka et al. Effect of angiotensin receptor blockers on cardiovascular events in patients undergoing hemodialysis: an open-label randomized controlled trial Am J Kidney Dis 52 3 2008 501 506
60. A. Takahashi, H. Takase, T. Toriyama, T. Sugiura, Y. Kurita, and R. Ueda et al. Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis - a randomized study Nephrol Dial Transplant 21 9 2006 2507 2512
61. H. Tamez, C. Zoccali, D. Packham, J. Wenger, I. Bhan, and E. Appelbaum et al. Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease Am Heart J 164 6 2012 902 9.e2
62. J.M. Testani, J. Chen, B.D. McCauley, S.E. Kimmel, and R.P. Shannon Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival Circulation 122 3 2010 265 272
63. E.C. Theil Iron, ferritin, and nutrition Annu Rev Nutr 24 2004 327 343
64. K. van der Putten, K.E. Jie, D. van den Broek, R.J. Kraaijenhagen, C. Laarakkers, and D.W. Swinkels et al. Hepcidin-25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease/chronic heart failure patients Eur J Heart Fail 12 9 2010 943 950
65. Y. Wang, J. Zhu, and H.F. DeLuca Where is the vitamin D receptor? Arch Biochem Biophys 523 1 2012 123 133
66. A.R. Webb Who, what, where and when-influences on cutaneous vitamin D synthesis Prog Biophys Mol Biol 92 1 2006 17 25
67. D. Wencker Acute cardio-renal syndrome: progression from congestive heart failure to congestive kidney failure Curr Heart Fail Rep 4 3 2007 134 138
68. C.W. Yancy, and A. Singh Potential applications of outpatient nesiritide infusions in patients with advanced heart failure and concomitant renal insufficiency (from the Follow-Up Serial Infusions of Nesiritide [FUSION I] Trial) Am J Cardio 98 2 2006 226 229